Study to Evaluate Safety & Tolerability of BMS-906024 in Combination With Chemotherapy & to Define DLTs & MTD of BMS-906024 in Combination With One of the Following Chemotherapy Regimens; Weekly Paclitaxel, 5FU+Irinotecan or Carboplatin+Paclitaxel in Subjects With Advanced / Metastatic Solid Tumors
Clinical trial NCT01653470 · COMPLETED
Trial details
- NCT number
- NCT01653470
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-12
- Primary completion
- 2017-05-03
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.